NCPA - National Center for Policy Analysis

Strong Opposition to Change in Part B Drug Reimbursements

May 13, 2016

A recent proposal to change how doctors are paid for oncology drugs has drawn opposition from Congress. This is unfortunate given that the Administration proposal merely sought to equalize the physicians profit from low-cost and high-cost drugs.


Browse more articles on Health Issues